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The adsorption of antithrombin III (AT Ill) onto polystyrene surfaces preadsorbed with albumin or albumin- 
heparin conjugates was studied using a two step enzyme immuno assay. When AT Ill- buffer solutions were used 
the highest adsorption values were measured on high affinity albumin-heparin conjugate pretreated surfaces. 
Less AT III adsorption was found on nonfractionated albumkheparin conjugate preadsorbed surfaces. AT III 
adsorption could also be detected on low affinity conjugate and albumin coated surfaces When AT Ill was 
adsorbed from plasma or plasma dilutions with buffer, only AT III on surfaces preadsorbed with high affinity or 
nonfractionated albumkheparin conjugate was found. These results demonstrate that the heparin moiety of the 
conjugate is directed to the solution phase whereas the albumin moiety contacts the polystyrene surface. 
Keywords: Polymers, heparin, albumin-heparin conjugates, antithrombin 111, protein adsorption 
The mechanism by which heparin acts as an anticoagulant 
has been the subject of many papers. It is now generally 
accepted that heparin requires the participation of the 
natural coagulation inhibitor antithrombin III (AT Ill) to 
express its activity. As shown by spectroscopic 
techniques’-3, heparin binds strongly to AT III and induces 
a conformational change of this protein. The heparin- 
AT III complex rapidly neutralizes the activity of activat- 
ed clotting factors (thrombin, factors Xlla, Xla, Xa, IXa) 
yielding an inactive heparin-AT Ill-clotting factor com- 
plex. Subsequently, heparin is released from this ternary 
complex and is then available for further reactions. 
A review concerning the mechanism of the anticoagulant 
action of heparin was recently published by Bjork and 
Lindah14. The binding of AT Ill to heparin is not only 
important for the anticoagulant activity, but also plays a 
role in hepariwplatelet interactions as was observed for 
heparin in solution5’6 as well as for immobilized heparin’. 
Although the mechanism of the anticoagulant action of 
heparin in solution is well known, the reasons for the 
observed enhanced antithrombogenicity of materials after 
heparinization are still not fully understood. Both the 
release of heparin from the surface into the blood phase as 
well as the action of surface bound heparin have been 
mentioned as causes for the observed enhanced 
antithrombogenicity*-lo. Although the role of AT III 
binding onto heparin in solution has been extensively 
investigated, the adsorption of AT III onto heparinized 
materials has received less attention”. ‘*. 
Recently we reported on the use of albumi-heparin 
conjugatesforthe improvement of the blood compatibility 
of polymeric surfaces either by preadsorption or by 
covalent coupling of the conjugates13. The in vitro blood 
compatibility of materials preadsorbed with albumi* 
heparin conjugates was strongly improved. Compared 
with control materials, platelet adhesion onto materials 
preadsorbed with albumir+heparin was reduced14 and it 
was shown that these surfaces also inhibited the surface 
induced coagulation’5S 16. 
As pointed out above, binding of AT III onto 
heparinized materials is possibly important for both the 
neutralization of formed activated clotting factors at the 
blood-polymer interface and for reduction of immobilized 
heparikplatelet interactions. In this paper we describe 
the results of the adsorption of AT III from plasma and 
from buffer containing purified AT III onto polystyrene 
preadsorbed with different albumiwheparin conjugates 
and albumin. A two step enzyme immuno assay (EIA) as 
described by Breemhaar et al.“, ‘* was used to detect 
adsorbed AT Ill. 
MATERIALS AND METHODS 
Materials 
All experiments described here were carried out using 
multiwell polystyrene microtitre plates (1 10 wells) 
obtained from Organon Technika, Turnhout, Belgium. 
0 1984 Butterworth Et Co (Publishers) Ltd. 0142-9612/84/050264-05$03.00 
264 Biomaterials 1984. Vol 5 September 
Interaction of antithrombin III: W.E. Hennink et al. 
Reagents 
Human serum albumin (A 951 1) was obtained from 
Sigma, St Louis, USA. Heparin (170 U/mg) from porcine 
mucosa was obtained from Diosynth, Oss, The Nether- 
lands. 1 -Ethyl-3-(3-dimethylaminopropyl)-carbodiimide 
(EDC) was a product of Aldrich, Beerse, Belgium. Purified 
human antithrombin III (AT Ill) was a generous gift of the 
American Red Cross. Human CPD plasma was obtained 
from the bloodbank Twente and Achterhoek, Enschede, 
The Netherlands. Rabbit sera directed against human 
albumin, human AT III and sheep serum directed against 
rabbit immunoglobulin (ShalgG) were obtained from the 
Central Laboratory of the Netherlands Red Cross Blood 
Transfusion Service, Amsterdam, The Netherlands. Horse 
radish peroxidase was purchased from Boehringer, 
Mannheim, FRG. Urea peroxide was a product of Organon 
Technika, Turnhout, Belgium. 3, 3’, 5, 5’-Tetramethyl- 
benzidine was purchased from Fluka, Switzerland. N-suc- 
cinimidyl-3-(2-pyridyldithio)propionate (SPDP) was ob- 
tained from Pharmacia Fine Chemicals, Uppsala, Sweden. 
Synthesis of the enzyme-anti-immunoglobulin conjugate 
Sheep anti-rabbit immunoglobulin G was covalently 
coupled to horse radish peroxidase using SPDP as a 
coupling agent The procedure was described in detail by 
Carlsson et al. lg. 
Albumin-heparin conjugates 
Albumin and heparin were coupled using a water soluble 
carbodiimide (EDC). Unreacted albumin and heparin were 
separated from albumiwheparin conjugates using DEAE 
cellulose and Cibacron Blue Sepharose chromatography 
respectively, as described in detail previously’3. High and 
low AT III affinity albumin-heparin conjugates were 
obtained by fractionation using immobilized AT lll13. The 
albumin-heparin conjugates obtained were characterized 
with respect to the weight percentage of heparin in the 
conjugates using a metachromic assay’3,20 and the 
anticoagulant activity using an APlT (activated partial 
thromboplastin time) assay13. 
Adsorption of albumin, albumin-heparin conjugate and 
AT Ill onto polystyrene 
Solutions of albumin, albumin-heparin conjugate and AT 
III were made in PBS (phosphate buffered saline, 0.9% 
NaCI, 10 mM NazHP04 adjusted with HCI to pH 7.4). AT III 
concentrations were determined spectrophotometrically 
at 280 nm using an extinction coefficient ,$zo nm = 6.10”. 
The wells of polystyrene microtitre plates were 
contacted for 1 h at 20°C with 75 E_LI of serial dilutions of 
albumin (concentrations varied from 1 Op5- 10 mg/ml), 
albumiwheparin conjugate (concentrations varied from 
1 0p5- 10 mg/ml) or AT III (concentrations varied from 
lops-2 x 10-l mg/ml) solutions in PBS. 
After the addition of the protein solutions, the plates 
were covered in order to prevent evaporation. The protein 
solutions were then discarded and each well was 
sequentially washed4 times with 150 ~1 aliquots of PBS. 
After washing, 50 ~1 of a solution of anti-albumin (first 
antibody) was added to the wells which were previously 
exposed to the albumin and albumiwheparin conjugate 
solutions and 50 ~1 of a solution of anti-AT III was added 
to the wells which were previously exposed to the 
different AT III solutions. The solutions of anti-albumin 
and anti-AT III were prepared by dilution of rabbit serum 
directed against human albumin and human AT III 
respectively a 100 times in PBS-BSA [PBS containing 1% 
(w/v) of bovine serum albumin]. The adsorbed proteins 
were incubated with the corresponding antibody solution 
for 1 h. Subsequently the antibody solution was discarded 
and each well was sequentially washed 4 times with 
150 ,ul aliquots of PBS. Then 50 ~1 of an appropriate 
dilution of enzyme coupled anti-immunoglobulin (second 
antibody) in 0.02 M Tris/HCI buffer containing 1% (w/v) 
polyethylene glycol 6000 (obtained from Fluka. 
Switzerland) was added to each of the wells. After an 
incubation time of 1 h, the solution of the second antibody 
was discarded and each well was washed 4 times with 
150 ~1 of PBS after which 100 ,u.l of substrate solution 
was added to each well. The substrate solution was 
prepared by diluting a 3, 3’, 5, 5’-tetramethylbenzidine 
(10 mg/ml DMSO) solution 100 times in buffer (0.6 M 
Na acetate, pH 6.0) which contained 1 ml of a stock ureum 
peroxide solution (1 tablet per 10 ml H,O) per 100 ml. The 
polystyrene plate was placed in the dark for 30 min. 
followed by the addition of 2 M HxS04 to stop the 
enzymatic reaction. Finally the intensity of the yellow 
colour formed was measured at 450 nm using a 
calorimeter (Vitatron) equipped with a 80 ~1 flow through 
cell. 
Adsorption of AT Ill onto polystyrene preadsorbed with 
albumin or albumikheparin conjugate 
To evaluate AT III interactions with adsorbed albumin or 
albumi*heparin conjugates, 75 ~1 of a solution of 
albumin or albumin-heparin conjugate (5 mg/ml in PBS) 
was first pipetted into the wells of a polystyrene plate. 
After 1 h incubation the albumin and albumipheparin 
conjugate solutions were discarded and the wells were 
washed with PBS as described above. Then 60 PI of AT Ill 
solutions (1 Op5 -2 X 10-l mg/ml in PBS) or plasma 
(undiluted- 1 O5 times diluted in PBS) were added to the 
preadsorbed surfaces and incubated for 1 h. The plasma 
and AT III solutions were then discarded and the wells 
were washed with PBS using the procedure described 
above. Subsequently 50 ~1 of anti-AT III solution was 
added and the remainder of the test was conducted as 
described before. 
RESULTS 
Table 7 presents the results of the fractionation of 
albumirr-heparin conjugate with immobilized AT Ill. Since 
the compositions of the different conjugates do not differ 
substantially, only the adsorption isotherm of 
nonfractionated albumiwheparin conjugate on poly- 
styrene was determined and compared with the one 
obtained for albumin. 
Table 1 Characterization of albumin-heparin conjugates 
ConJugate Wwght % of heparin Antroagulant activity* 
in U/mg heparin 
nonfractlonated 10.9 f 0.5 76 i 6 
high affinity 10.8 zk 0.6 150112 
low affinity 9.3 + 0.4 13 F4 
*Using an AP- assay with heparln (1 70 U/mg) as a standard. 
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Figure ? shows the adsorption isotherms observed 
for albumin and albumin-heparin conjugate on 
polystyrene as studied with the two step immuno assay. 
At higher concentrations (> 10-l mg/ml), extinctions are 
statistically indistinguishable for albumin and the 
aibumi~heparin crnjugate, whereas at lower 
concentrations (1 Op5- 1 OS2 mg’ml) slightly lower 
extinctions for the albumin-heparin conjugate were 
usually observed (5 independent experiments). 
Figure 2 shows the adsorption isotherm of AT III 
onto a polystyrene surface. When plasma or plasma 
ditutions( up to 10” times) were used as a source of AT Ill, 
no adsorption of AT Ill onto polys~rene could be 
detected. 
Figure 3 shows the results of the adsorption of AT III 
onto polystyrene preadsorbed with albumin, non- 
fractionated albumiwheparin conjugate and low and high 
affinity albumin-heparin conjugate. Besides a significant 
adsorption of AT Iii onto nonfractionated and high affinity 
albumin-heparin conjugate, surprisingly, also on albumin 
and low affinity albumin-heparin conjugate preadsorbed 
polystyrene some adsorption of AT III was observed. As an 
internal control, AT III adsorption from PBS containing a 
o$ 9 / I / L 3 
lo+ lo-4 lo‘3 1o-2 10-l I IO 
olb,alb-hep(mg/mL) 
Figure 1 Adsorption isotherms of albumin (0) and albumin-heparin 
conjugate ( 0) on polystyrene. AN plotted points are the mean of 5 
measurements. 
AT ILI (mg/mL) 
Figure 2 Adsorption isotherm of AT III on polystyrene. All plotted 
points ara the mean (k S. 0.) of 34 measurements. 
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Figure 3 Adsorption of AT III from buffer containing different 
concentrations of purified AT Ill onto polystyrene praadsorbed with 
albumin ( 0), nonfraetjonated albumin~eparin conjugate ( 17). high 
affinity albumin-beparin conjugate ( 0 ) and low afrinity albumin- 
heparin conjugate (A). Allplottedpoints are the mean of 34 measure- 
ments. 
physiological concentration of AT III (0.2 mg/mlz2) was 
studied for each polystyrene plate used. The extinctions 
obsen/ed for adsorption of AT Ill onto preadsorbed 
albumin and albumi~heparin conjugate surfaces can 
then be related to the extinctions obtained for AT Ill 
adsorption from a 0.2 mg/ml solution onto bare 
polystyrene. From Figure 3 it can be calculated that the 
percentage AT Ill adsorption of surfaces preadsorbed with 
albumin, low affinity albumi~heparin conjugate, 
nonfractionated albumi~heparin conjugate and high 
affinity albumin-heparin conjugate was 21%, 27 %, 38% 
and 65% respectively. Dependent on the batch of 
polystyrene plates and AT III used, the AT III adsorption 
ratios differed widely. For preadsorbed albumin, values 
between 15 and 70% were observed and for preadsorbed 
albumi~heparin conjugate (nonfra~tionated) these 
values varied from 35-100%. In spite of the relatively large 
differences in AT III adsorption percentages observed on 
the same protein coating, in every experiment the 
albumin-heparin conjugate preadsorbed surfaces 
showed a significant higher adsorption of AT Ill than the 
albumin preadsorbed surfaces. The adsorption of AT Ill 
onto albumin preadsorbed surfaces could not be reduced 
by increasing the concentration of the albumin solution 
(up to 10 mg/ml). In addition, no reduction in adsorption 
of AT III onto albumin preadsorbed surfaces was observed 
when after the incubation of the albumin preadsorbed 
surfaces with AT III the wells were washed with PBS 
containing 0.75 M NaCl. 
Figure4 shows the adsorption behaviour of AT Ill on 
surfaces preadsorbed with albumin and different albumin- 
heparin conjugates using plasma or plasma dilutions as a 
source of AT Ill. From this figure it appears that high 
affinity and nonfractionated albumi~heparin conjugate 
preadsorbed surfaces bind substantial amounts of AT Ill. 
On the other hand on surfaces preadsorbed with albumin 
and low affinity albumiwheparin conjugate no AT III 
adsorption from plasma could be detected with the EIA 
technique used. 
DISCUSSION 
No substantial differences in adsorption behaviour of 
albumin and albumikheparin conjugate on polystyrene 
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Figure 4 Adsorpt/on of AT III from plasma and plasma drlutions m 
buffer onto polystyrene preadsorbed with albumin (0). non- 
fractionated albumin-heparin conjugate ( 0). high affinity albumin- 
heparin conjugate ( l ) and low affinity albumin-heparin conjugate (A). 
All plotted points are the mean of 3-4 measurements. 
were observed, with the EIA technique used. The 
observation that at lower concentrations of albumin and 
albumin-heparin conjugate the extinctions for albumi- 
heparin conjugate were slightly lower than for albumin 
indicates that either the surface concentration of 
albumiwheparin conjugate is slightly lower or the 
immunological affinity of anti-albumin for the albumin 
heparin conjugate is lower than for albumin. Possibly the 
binding of heparin to albumin blocked some of the anti- 
albumin binding sites present on the albumin molecule. 
As known from affinity chromatography data, 
immobilized heparin is able to bind AT 1112’ as well as a 
number of other plasma proteins such as factor IX and 
Xl15, 23. As expected, polystyrene preadsorbed with high 
affinity and nonfractionated albumic-heparin conjugate 
binds a significant amount of AT III when exposed to 
buffer containing AT III or to plasma. In all experiments, 
higher amounts of AT III were bound to preadsorbed high 
affinity albumipheparin conjugate than to non- 
fractionated conjugate. This can be explained by the 
observation that only 3040% of nonfractionated 
heparin is able to bind AT ll124~25. Surprisingly, albumin 
and low affinity albumirr-heparin preadsorbed surfaces 
also bind some AT III when exposed to buffer containing 
purified AT Ill. Three possible explanations for this 
observation can be given: 
(1) adsorbed albumin binds AT Ill; 
(2) the polystyrene surface was not completely coated 
with albumin, providing free surface for binding 
with AT Ill; 
(3) AT III replaces albumin from the polystyrene surface. 
The following observations are of importance: AT III 
bound to albumin preadsorbed polystyrene surfaces could 
not be removed by washing with 0.75 M NaCl which 
indicates that electrostatic interactions play a minor role; 
when polystyrene was precoated with albumin using 
solutions with a concentration of 10 mg/ml instead of 
5 mg/ml no decrease in the adsorption of AT III was 
observed. Exchange of preadsorbed albumin with 
proteins in solution has been reported In the literature26,27 
and because the EIA technique is very sensitive, only a 
small amount of AT III which has displaced albumin can 
result in a substantial extinction. No adsorption of AT III 
from plasma onto albumin preadsorbed surfaces could be 
detected, which indicates that a possible binding of AT III 
from buffer solutions to adsorbed albumin does not have a 
physiological meaning. 
The fact that the heparin moiety of adsorbed 
albumirr-heparin conjugate can bind AT Ill indicates that 
the adsorption of albumin-heparin conjugate mainly 
occurs via the albumin portion with the heparin moiety 
residing in the aqueous solution phase. 
From the study, it can be concluded that after 
contact between plasma and albumin-hepann conjugate 
preadsorbed polystyrene, adsorption of AT III takes place. 
It was demonstrated that this specific adsorption was due 
to interaction between AT III and the heparin moiety of the 
conjugate. The binding is dependent on the type of 
heparin (low or high affinity for AT Ill) used. From the fact 
that AT III is specifically adsorbed from plasma onto non- 
fractionated and high affinity albumin-heparin conjugate 
preadsorbed surfaces, it can be concluded that for these 
surfaces AT III also plays a role in the subsequent 
interaction with clotting factors and platelets. 
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